HIV and HEDIS: What Do Clinicians Need to Know

One of the most essential duties of individuals who care for people living with HIV (PLWH) is to ensure that their health care is of the highest quality. The National Committee for Quality Assurance (NCQA) has developed the Healthcare Effectiveness Data and Information Set (HEDIS) that is the largest quality measurement program in the United States and measures quality across six domains of care and associated scores for health plans. Utilizing HEDIS and other quality measures is particularly important for clinicians who treat PLWH, as deficiencies in care, such as HIV medication adherence or in identification and treatment of comorbidities, can have serious impacts on health and long-term wellbeing.

In this CMEO Snack, expert faculty will share strategies for identifying aligned HEDIS measures pertaining to HIV care, integrating quality measures as a standardized process in clinical practice, as well as documenting the utilization of quality measures to assess impact of quality care on patient outcomes.

At the conclusion of this activity, learners will be able to better:

• Identify aligned HEDIS measures and NCQA guidelines pertaining to HIV care
• Integrate quality measures as a standardized process in clinical practice
• Document utilization of quality measures to assess impact of quality care on patient outcomes

Supported by an independent educational grant from Gilead Sciences, Inc.

PCPs, FPs, internists, HIV specialists, physician associates (PAs), nurse practitioners (NPs), and nurses 

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. Relevant financial relationships exist between the following individuals and commercial interests:

Dr. Lawson reports the following financial relationships:

Advisory Board: Gilead Sciences, Inc. and ViiV Healthcare

Consultant: RxEACH Initiative

Grants: National Institute on Minority Health & Disparities Scientific Lead and Robert Wood Johnson Foundation

Research Support: ViiV Healthcare/GSK

Speakers Bureau: Eisai Inc.; Gilead Sciences, Inc.; National Dairy Council; Pfizer Inc.; and ViiV Healthcare

Dr. Palakodeti reports no financial relationships to disclose.

The following individuals have no financial relationships to disclose:

Jeffrey Helfand, DO (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Evan Luberger (Planning Committee)
Estelle Perera (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Call us at 877.CME.PROS (877.263.7767).

SN-254-031025-47